Elysian Capital announces acquisition of Facilis Group in USA

Elysian Capital

Elysian Capital LLP (‘Elysian’) is delighted to announce that it has made its second investment into the promotional products sector following its investment in Brand Addition in May 2017.

Elysian has acquired Facilis Group (Facilis), a core service provider to more than 120 entrepreneur led distributor businesses (its Partners) in the fragmented $26bn North American promotional products industry.

Facilis provides unparalleled services to its Partners via a subscription based service providing best-in-class sales workflow and website technology, preferred supplier contracts and supply chain tools, and a vibrant community network. These three service pillars support and enable their Partners and preferred suppliers to grow.

Both Facilis and Brand Addition are market leading companies within their respective specialist sectors of the large and growing promotional products sector where they deliver unique services to their Partners and clients that set them apart from their competition. Brand Addition, itself a Facilis Partner in the US for ten years, provides the complex services necessary to support the promotional product programmes and agendas of large corporates across the US, Europe and Asia.

Whilst retaining their separate brands, growth strategies and management teams, Facilis and Brand Addition will be under common ownership within Elysian. There are a number of exciting opportunities for Facilis and its Partners with Brand Addition given the group’s combined business spend, enhanced geographic presence and continued investment in technology.

Dan Rochette, Martin Weber and Chuck Fandos, the former owners of Facilis, together with their wider management team all remain with the business.

 

Chuck Fandos, CEO of Facilisgroup said:

“Dan, Martin and myself believe that Elysian will be a strong investor as we continue to grow and evolve Facilis group. They share in our vision and mirror our mission to help our Partners be ever more competitive and successful.”

 

Tom Falcon, Chairman of The Pebble Group and Operating Partner of Elysian Capital LLP said:

‘We are really excited about our investment in FacilisGroup, our second in the industry. In Facilis we see a committed and extremely capable team helping their terrific community of Partners grow via their industry leading technology and supply chain.”

 

For further information, please contact:

Tom Falcon, Partner at Elysian Capital       tom@elysiancapital.com

Categories: News

Tags:

TA Associates to Invest in Netsmart Technologies

TA associates

BOSTON and OVERLAND PARK, KS – TA Associates, a leading global growth private equity firm, today announced that it has signed a definitive agreement to invest, alongside GI Partners, in Netsmart Technologies, Inc. (“Netsmart” or “the Company”).

Netsmart is a leading healthcare software company delivering management process solutions and electronic medical records to the health and human services (HHS) and post-acute end markets. TA Associates and GI Partners, a current shareholder in Netsmart, will acquire the stake in Netsmart held by Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX). The transaction is expected to close in the fourth quarter of 2018 and is subject to customary closing conditions. Financial terms of the transaction were not disclosed.

Founded in 1968, Netsmart provides software and services to the HHS and post-acute markets. The Company’s products, comprised primarily of electronic health records (EHRs) and related offerings, address the clinical, financial and administrative needs of its clients. The Netsmart suite includes care coordination, connectivity and integration, analytics, benchmarking, consumer engagement, mobility and telehealth offerings, among others. The largest provider of its kind in the United States, Netsmart serves more than 600,000 users from over 25,000 organizations across the country within four core areas: behavioral health, social services, care at home and senior living. The Company is headquartered in Overland Park, Kansas, with additional offices in Arkansas, California, Illinois, Missouri, New York, North Carolina and Ohio.

“We are excited to partner with the leading healthcare technology provider serving these growing and important end markets,” said Mark H. Carter, a Managing Director at TA Associates who will join the Netsmart board of directors. “Netsmart’s compelling attributes include a high-quality business model, a large and diversified customer base and software solutions that we believe are mission critical. We welcome the opportunity to work with Netsmart CEO Mike Valentine, whom we have known for many years, and with the investment professionals at GI Partners.”

“Since our founding, Netsmart has sought partners who share our commitment to excellence and quality healthcare outcomes,” said Mike Valentine, CEO of Netsmart. “TA Associates brings decades of experience investing in the healthcare industry and supporting efficiency, quality care and cost containment. Along with the team at GI, I am delighted to welcome TA as an investor and look forward to a close collaboration in continuing the evolution of Netsmart.”

Netsmart estimates the addressable market for HHS, home health, and long-term care software and technology solutions at $25 billion annually. According to the Company, the U.S. market for its core product offering is approximately $14.5 billion, with behavioral health comprising nearly half of that figure.

“Increasingly complex clinical, billing and regulatory requirements, and the need to measure and report patient outcomes, are accelerating the adoption of Netsmart’s software solutions,” said Hythem T. El-Nazer, a Managing Director at TA Associates who also will join the Netsmart board of directors. “In addition, as the HHS and post-acute industries continue to consolidate and expand, the need for technology solutions to coordinate care and drive efficiency will grow. As the leader addressing the unique and complex billing needs of customers spanning the continuum of care, we believe that Netsmart is very well positioned for continued growth.”

Kirkland & Ellis is providing legal counsel and Deloitte is serving as financial advisor to TA Associates.

About Netsmart
Netsmart designs, builds and delivers electronic health records (EHRs), solutions and services that are powerful, intuitive and easy-to-use. The Company’s platform provides accurate, up-to-date information that is easily accessible to care team members in behavioral health, care at home, senior living and social services. Netsmart makes the complex simple and personalized so clients can concentrate on what they do best: provide services and treatment that support whole-person care. By leveraging the powerful Netsmart network, care providers can seamlessly and securely integrate information across communities, collaborate on the most effective treatments and improve outcomes for those in their care. The Company’s streamlined systems and personalized workflows put relevant information at the fingertips of users when and where they need it. To learn more about how Netsmart is changing the face of healthcare today, please visit www.ntst.com.

About TA Associates
Now in its 50th year, TA Associates is one of the largest and most experienced global growth private equity firms. Focused on five target industries – technology, healthcare, financial services, consumer and business services – TA invests in profitable, growing companies with opportunities for sustained growth, and has invested in more than 500 companies around the world. Investing as either a majority or minority investor, TA employs a long-term approach, utilizing its strategic resources to help management teams build lasting value in growth companies. TA has raised $24 billion in capital since its founding in 1968 and is committing to new investments at the pace of $1.5 to $2 billion per year. The firm’s more than 85 investment professionals are based in Boston, Menlo Park, London, Mumbai and Hong Kong. More information about TA Associates can be found at www.ta.com.

 

 

 

 

Stamina Group AS sold to a fund managed by Norvestor Equity AS

Hercules Capital

Herkules Private Equity Fund III has entered into an agreement to sell Stamina Group AS to a fund managed by Norvestor Equity AS. Stamina Group is the leading provider of Occupational Health Services (“OHS”) in the Nordics with a nation-wide presence in Norway and Sweden.
After a disappointing start of the ownership, several changes were made in the beginning of 2016, including implementation of a completely new strategy. Since then, the company has completed a full turnaround. Non-core business areas, all loss-making when the turnaround was decided, were divested after successful implementation of several profitability improvement initiatives. In parallel, several operational and strategic efforts were implemented in the core OHS business, resulting in a positive development with strong organic revenue growth and more than tripled EBITDA.

Gaute Gillebo commented: “We are very pleased with the company’s development following the comprehensive strategy change in 2016. We are impressed by how management and the employees have responded following the changes and by the strong results they have generated. Stamina is now stronger than ever and ready to realize its full potential.”

The Herkules transaction team was led by Gaute Gillebo and supported by Fredrik Toft Bysveen.

Herkules Private Equity Fund III was advised by DNB Markets, Schjødt, and PwC.

Contact information:
Gaute Gillebo, Co-Managing Partner at Herkules Capital, +47 45 83 00 00

Categories: News

Tags:

Monaghan Mushrooms acquires 100% of Walkro, a leading producer of substrate for the mushroom industry

GIMV

Irish company Monaghan Mushrooms has agreed to acquire all shares of Walkro held by Gimv and Walkro’s management.

Walkro (www.walkro.eu) was founded in Belgium in 1991 and has grown into one of the largest producers of substrate for the mushroom industry. Walkro produces 8,500 tons of substrate per week at its production facilities in Maasmechelen (Belgium), Blitterswijck (the Netherlands) and Wallhausen (Germany). With more than 235 employees, Walkro sources its own raw materials (mainly horse and poultry manure), produces best in class substrate and takes care of transport to mushroom growers all over the world.

At the end of 2011, Walkro was acquired by operating partner Monaghan Mushrooms, together with financial investor Gimv and Walkro’s management team. Since then, Walkro’s turnover has grown to just over EUR 75 million (2017), making Walkro one of the largest producers of mushroom substrate in the world. Today, co-shareholder Monaghan buys out both Gimv and management, becoming the group’s sole shareholder.

In the new structure, Walkro will remain focused on producing high-quality mushroom substrate for independent growers around the world. The Walkro management underlines its confidence in the new structure by acquiring shares on Monaghan level. The current statutory management of Walkro, consisting of Eric Houben (CEO) and Peter Fijneman (CFO), will be responsible for all European substrate activities within the Monaghan group in similar positions, which has a total size of 15,000 tons of mushroom substrate per week. Eric Houben will also become a board member of Monaghan Mushrooms.

Monaghan Mushrooms (www.monaghan-mushrooms.com) is one of the world’s largest substrate and mushroom companies. The company is a ‘spore to store’ vertically integrated agribusiness meaning that it produces substrate for the cultivation of mushrooms and grows, harvests and packs quality and fresh mushrooms before delivering its mushrooms directly to its customers, some of the largest international retailers. The company is owned by the Wilson family (Ireland). Monaghan employs more than 3,500 employees and is headquartered in County Monaghan, Ireland. The group further has operations in Canada, the United Kingdom, Belgium, Netherlands and Germany.

Over the entire holding period, the investment in Walkro generated a return above Gimv’s long-term average return. No further financial details will be disclosed.

Categories: News

Tags:

AVS Verkehrssicherung acquires Traffics A/S

Triton

Kürten (Germany) / Gadstrup (Denmark), 10 December 2018 – AVS Verkehrssicherung (AVS), a Triton Fund IV company, has acquired Traffics A/S (“Traffics”), a Danish provider of construction site- and traffic security, headquartered in Gadstrup (Denmark). The purchase price has not been disclosed.

Founded in 2006, Traffics offers complete solutions, services and equipment for construction sites- and traffic security. Its customers are road construction companies as well as public works and communities.

“We have a long standing business relationship with Traffics based in trust. Together, AVS and Traffics can offer a wide range of products and services which cater to the highest demands of customers in the Danish market;” comments Dirk Schönauer, Managing Director at AVS.

About AVS Verkehrssicherung
AVS Verkehrssicherung is a leading specialist provider of highway traffic safety services in Germany. The Company, headquartered in Kuerten, offers all essential services throughout highway traffic-safety projects. These services range from initial planning and obtaining permits to complete construction site setup and security. AVS has a nationwide presence with 14 locations across Germany and around 600 employees.

For further information: http://www.avs-verkehrssicherung.de

About Triton
The Triton funds invest in and support the positive development of medium-sized businesses headquartered in Europe, focusing on businesses in the Industrial, Business Services and Consumer/Health sectors.

Triton seeks to contribute to the building of better businesses for the longer term. Triton and its executives wish to be agents of positive change towards sustainable operational improvements and growth. The 37 companies currently in Triton’s portfolio have combined sales of around € 12.9 billion and around 83,000 employees.

The Triton funds are advised by dedicated teams of professionals based in Germany, Sweden, Norway, Finland, Denmark, Italy, the United Kingdom, the United States, China, Luxembourg and Jersey.

Press Contacts

AVS Verkehrssicherung
Dirk SchönauerTel.: +49 (0) 214 313834 – 11
dirk.schoenauer@avs-verkehrssicherung.de

Triton
Marcus Brans
Tel.: +49 69 921 02204

Categories: News

Tags:

KKR Appoints Sumanth Cidambi and Vijay Padmanabhan as Directors in its India Credit Business

KKR

Appointment Aimed at Meaningfully Scaling Credit Operations in India

MUMBAI, India–(BUSINESS WIRE)–Dec. 4, 2018– KKR today announced the appointment of Sumanth Cidambi and Vijay Padmanabhan as Directors for the firm’s credit business in India. Both the appointments will help KKR deepen and scale its existing India credit strategy and move into adjacencies.

KKR has been the pioneer in developing private high-yield and structured credit investing in India. The firm operates in the credit space through an NBFC and Alternative Investment Funds, suitably complemented with global capital pools. Since 2009, the firm has executed on over 140 transactions in India, valued at close to US$6 billion.

Speaking on the appointments, BV Krishnan, Member, KKR, and CEO, KKR India Financial Services, said: “Both Sumanth and Vijay join our team at a very opportune time. Sumanth brings to us the much necessary owner-operator mindset and has a track record of delivering sustainable value. He will complement our focus on building capabilities in the operational turnaround and workout areas, which are becoming a critical differentiator in credit investing in India.”

He further added, “Vijay brings on board deep credit underwriting experience. He has a unique risk-reward perspective, having worked in the UK and India. His skill sets and understanding of the domestic eco-system give him a wholesome understanding of what it takes to succeed in this space. His ability to underwrite across the capital structure will be a critical element in our plan to further scale our platform where we have been the market leader in private high-yield investing.”

With nearly two and a half decades of diversified industrial experience, Sumanth Cidambi has worked extensively with corporate boards and senior management teams in Asia, Europe and the US, to create sustainable value. Leveraging his deep experience in operations restructuring and business turnarounds, he will work closely with KKR’s credit portfolio companies in India to deliver identified and specific value. Sumanth’s addition highlights the firm’s strong view that operational involvement in companies is a dimension that is critical to delivering value to stakeholders, and risk managing outcomes.

Vijay Padmanabhan has extensive experience in credit underwriting and distress investing, in the UK and India, including in Old Lane, Fidelity Investments, SBI Funds Management, PricewaterhouseCoopers, and Edelweiss Alternative Asset Advisors.

Early this year, KKR’s India Financial Services made two Director level hires viz. Jigar Shah as the Legal and Compliance Head for the firm in India, from JP Morgan, and Niraj Karia as a senior credit originator, from Kotak Investment Bank.

KKR has been investing in India since 2006. In addition to a strong private equity practice, KKR is highly focused on credit, capital markets and real estate opportunities in India. Its credit portfolio in India includes, but is not limited to, Enzen Global Solutions, Amanta Healthcareand Walchandnagar Industries.

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate and credit, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE:KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

About KKR India Financial Services

KKR India Financial Services (“KIFS”) is KKR’s alternative credit business in India that provides flexible financing to companies via a unique business model that comprises balance sheet — via a non-bank finance company —alternative asset management, and capital markets. As of Nov 30, 2018, KIFS has executed over 140 transactions in India worth close to US$6 billion.

Source: KKR

Media

For KKR Asia:
Cara Major
Cara.Major@KKR.com

For KKR India:
Edelman
Siddharth Panicker, +91-9820-857-522
Siddharth.Panicker@Edelman.com

Categories: People

Tags:

BBS Automation acquires industrial software specialist ANT

eqt

EQT portfolio company BBS Automation today announced the add-on acquisition of ANT – a leading developer of innovative “Industry 4.0” solutions that digitize production workflows in large-scale manufacturing processes.

Headquartered in Munich, Germany, BBS Automation develops flexible and high-quality automation solutions for complex manufacturing and testing processes. With production sites in Germany, the US, China and Malaysia, BBS Automation supports a diverse network of blue-chip customers on a global scale. EQT Mid Market Europe and EQT Mid Market Asia III jointly invested in BBS Automation alongside its founding families to support the growth ambitions of the company both organically and through add-on acquisitions.

BBS Automation and ANT – expanding offering of digital factory solutions

Better utilization of data analytics and IoT technologies represent an enormous opportunity for manufacturing companies across all sectors. The ability to increase the efficiency of assembly processes, allow for more rigorous testing and quality management practices as well as to enable predictive maintenance are only some of the manifold potentials that can be provided by integrated digital factory solutions.

In order to expand its offering in this regard, BBS Automation acquired the industrial software specialist ANT Sp. z o.o, a developer of highly innovative “Industry 4.0” solutions headquartered in Kraków, Poland. Founded in 2006 by Jerzy Fulara and Andrzej Jarosz, ANT has developed a core platform (“AOS”) that can be combined with highly customized software modules tailored to the specific needs of each customer.

Among other features, solutions of ANT include digital dashboards to visualize production workflows, data analysis tools to optimize machine efficiency, assistants to enable predictive maintenance and tools to digitize processes like documentation and quality control. One key strength of ANT’s solutions is the high compatibility with existing hardware and software infrastructures. Data can be drawn from a wide range of available machine sensors, complemented with ANT data acquisition modules wherever required. Analyses can subsequently be fed into a wide range of ERP-systems. This makes ANT a valuable partner for the digital transformation of existing factories, proven in more than 450 system implementations in more than 30 countries to date.

The combination of BBS Automation’s deep industrial automation expertise with ANT’s experience in software and data analytics will strengthen the ability to jointly develop integrated “Industry 4.0” solutions.

Uwe Behr, Co-founder of BBS Automation, comments: “In ANT we found our ideal counterpart among industrial software developers: ANT draws on a remarkable sector experience and truly understands the needs of its customers in their respective end markets, acting in close partnership with its clients to develop customized solutions of highest quality. With every new implementation they expand their ‘toolkit’ of capabilities. We are looking forward to partner up with its founders to combine our capabilities and jointly develop new innovative solutions that will allow our customers to master the digital transformation of their assembly and testing processes.”

Andrzej Jarosz, CEO and Co-founder of ANT adds: “Over the course of the last twelve years we expanded the depth and scope of our solution offering and were looking for a strong partner to further accelerate our growth. Our customers increasingly request us to serve them on a global scale. The global platforms of BBS Automation and EQT will allow us to better serve customers internationally. In addition, we see strong demand for our solutions in new end markets that BBS Automation already serves today and for which we will now work on customized solutions together.”

Andreas Fischer, Partner at EQT Partners and Investment Advisor to EQT Mid Market Europe concludes: “Both BBS Automation and ANT have a strong entrepreneurial culture and share a passion to build best-in-class solutions for their customers. EQT is thrilled to support this add-on acquisition only six months after investing in the company. This transaction is a strong fit, not only in terms of synergistic technologies and geographic expansion potential, but especially in terms of the cultural fit of both businesses and we welcome the decision of ANT’s founders to stay on board. EQT looks forward to jointly develop BBS Automation’s positioning as a key enabler of Industry 4.0 production systems.”

HQ Capital Gives Back! in New York

HQ Capital

New York, NY, 3 December 2018. HQ Capital’s New York office participated in a “Reading Party” for grade school children as part of the firm-wide HQ Capital Gives Back! Initiative.

More than 30 employees attended the event, hosted by Pajama Program, a national organization dedicated to providing new pajamas and books to vulnerable children in support of a caring bedtime ritual and good night’s sleep. The Reading Party began with introductions and then the children spent an hour reading with their adult “reading buddies.”  At the end of the Reading Party, the children each selected a book of their choice to take home and were presented with a new pair of pajamas, specially wrapped and labeled with their name. Each child was given a round of applause to encourage their participation in reading activities.

“As a parent of teenage children, the Reading Party brought back memories of reading to my own children. Knowing the importance of this activity made the experience especially meaningful,” said Chris Lawrence, Managing Director at HQ Capital. “The event was well-run, and the staff is extremely devoted and caring. It was truly rewarding to have contributed to the impact the Pajama Program is making in the lives of these kids.”

Pajama Program was founded in 2001 by Genevieve Piturro after she was asked by a young girl living in a shelter, “What are pajamas?” Piturro regularly read to children at a local shelter and was shocked to realize how many did not have pajamas to change into or a book to read before bedtime. She started the program with the goal of helping to transform bedtime into a loving ritual for children living in difficult circumstances. The program now serves children in every state and has delivered more than 3 million pajamas and over 2 million books.

“The number of employees who participated in the Reading Party is a testament to HQ Capital’s commitment to giving back to the community,” said Jeremy Katz, Co-Head of Real Estate at HQ Capital. “We are proud to have partnered with the Pajama Program and to have supported their mission of providing new pajamas and books to children who might not otherwise have them. We are continually looking for opportunities in which we can make a positive social impact.”

About Pajama Program

At Pajama Program, we understand deeply how many children in this country don’t have a stable home life, or a home at all. To these children — often abandoned, neglected, living in shelters or temporary housing — we pledge our unwavering commitment to the inherent right of every one of them to have a loving bedtime and restful good night as the start of a positive, empowering good day. New pajamas and books are magical gifts that we collect and give, with love, to vulnerable children. They inspire them, teaching them how to use imagination and creativity to change their lives in the moment, and every day. They are the building blocks of confidence, trust and love. Further information can be found at www.pajamaprogram.org.

Categories: News

Tags:

Leading Fintech Innovator Cross River Raises $100 Million Funding Round Led by KKR

KKR

KKR Makes $75 Million Investment and is Joined by CreditEase, Lion Tree Partners and Returning Investors Battery Ventures, Andreessen Horowitz and Ribbit Capital

FORT LEE, N.J.–(BUSINESS WIRE)–Cross River Bank (“Cross River” or the “Company”), a fast-growing provider of banking services for financial technology companies, announced today that it has completed a funding round of approximately $100 million, led by a $75 million equity investment from KKR. KKR is joined in the round by new investors, CreditEase and Lion Tree Partners, and by returning investors Battery Ventures, Andreessen Horowitz and Ribbit Capital.

Cross River combines innovative technologies with the trust, security and established expertise of a bank to create new services and solutions for fintech companies that are redefining global financial services. In addition to traditional banking, Cross River has developed partnerships with financial technology leaders to build fully compliant and integrated products for the marketplace lending and payment processing arenas. Current clients consist of leading technology brands, start-ups and financial services firms disrupting global finance including marketplace lenders Affirm, Best Egg, Upstart and RocketLoans as well as financial technology companies like Coinbase and TransferWise.

“We are very pleased that our growth and progress has the endorsement of leading investors such as KKR,” said Gilles Gade, founder, CEO and Chairman of Cross River. “We also welcome new investors CreditEase and Lion Tree Partners and are especially grateful for the continued confidence of our previous investors Battery Ventures, Andreessen Horowitz and Ribbit Capital. This is a very strong signal that we continue to execute on our plan and are poised to take Cross River through its next phase of successful development here in the U.S. and across the globe.”

The new funding round follows $28 million in venture capital secured in late 2016 from Battery Ventures, Andreessen Horowitz and Ribbit Capital.

This additional funding will enable Cross River to invest in the Company’s continued growth by expanding its technology and product development teams as well as its compliance infrastructure. The capital will allow Cross River to continue building and enhancing a complete banking platform where fintech companies can leverage best-in-class banking technology coupled with compliance excellence.

“We believe Cross River has a great future ahead and we are very pleased to support Gilles and the talented management team to continue their impressive growth,” said Dan Pietrzak, Member and Co-Head of Private Credit at KKR. “Cross River offers solutions to address a number of challenges faced by fintech companies by giving them access to a full suite of banking solutions and services in a single, fully compliant and innovative platform, making it an increasingly attractive and valuable franchise in a dynamic marketplace.”

KKR is making the investment primarily from its Private Credit Opportunities Partners II L.P fund.

About Cross River

Cross River Bank is a fast-growing financial services organization that merges the established expertise and traditional services of a bank, with the forward-thinking offerings of a technology company. They combine a fully compliant and comprehensive suite of products into a unique banking-as-a-platform solution, encompassing lending, payments and risk management. Cross River partners with leading marketplace lenders and fintech companies enabling them to focus on their own growth without hindering innovation. Founded in 2008, Cross River is a New Jersey state-chartered FDIC insured bank. For more information, please visit Cross River’s website at www.crossriver.com or the company’s Twitter @crossriverbank.

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate and credit, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE:KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

Contacts

Cross River
Robert Rendine/Robin Weinberg/Cameron Seligmann
Sard Verbinnen & Co.
Phone: 212-687-8080
CrossRiver-SVC@sardverb.com

KKR
Kristi Huller or Samantha Norquist
Phone: 212-750-8300
media@kkr.com

Categories: News

Impel NeuroPharma Closes $67.5 Million Series D Financing

KKR

Crossover Financing to Advance Clinical Development of Central Nervous System Assets in Migraine, Parkinson’s Disease and Acute Agitation

SEATTLE, Dec. 6, 2018 /PRNewswire/ — Impel NeuroPharma (“Impel” or the “Company”), a Seattle-based, privately-held biotechnology company focused on developing therapies for the treatment of central nervous system (“CNS”) disorders with unmet medical needs, today announced that it has completed a Series D financing totaling $67,500,000. The investment is co-led by KKR and Norwest Venture Partners (“Norwest”), with participation from existing investors, Vivo Capital, 5AM Ventures and venBio Partners.

In connection with the financing Dr. Robert Mittendorff, Partner at Norwest, and Ali Satvat, Member at KKR, will join the Impel Board of Directors.

This financing will enable Impel to accelerate its existing clinical development portfolio in CNS disorders. Impel is currently investigating three programs leveraging its novel Precision Olfactory Delivery, or POD®, device technology: INP104 in a Phase 3 trial for the treatment of acute migraine headache, INP103 in a Phase 2 trial for the reversal of OFF episodes in Parkinson’s disease and INP105 in a Phase 1 trial for the treatment of acute agitation in bipolar I and schizophrenia disorders.

“We are delighted to have the support of this exceptional group of both new and existing investors. Dr. Mittendorff and Mr. Satvat will be tremendous assets as new members of Impel’s Board of Directors and we believe that this investment is a testament to the strength of our POD® technology, our clinical programs and our management team,” said Jon Congleton, Chief Executive Officer of Impel. “With three product candidates progressing through various stages of clinical development in 2018, it has been an exciting year for Impel, and this financing confirms the value that we are generating with our clinical programs.”

“We are excited to have co-led this financing round with KKR and look forward to helping Impel reach its goals as the Company progresses the development of these novel investigative therapies,” said Dr. Mittendorff. “Norwest shares in Impel’s belief that the Company’s pipeline has the potential to bring important new treatments to the market for the CNS community.”

“We are thrilled to contribute to the development of innovative solutions that may enhance the lives of patients with CNS disorders,” said Mr. Satvat. “Impel’s proprietary, novel platform has the potential to transform intranasal drug delivery, significantly improving the range of treatment options for people living with acute migraine, acute agitation and Parkinson’s disease.”

About Impel NeuroPharma
Impel NeuroPharma, Inc., is a privately-held, Seattle-based biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel NeuroPharma is currently investigating INP104 (POD-DHE) for acute migraine headache, INP103 (POD-levodopa) for reversal of OFF episodes in Parkinson’s disease and INP105 (POD-olanzapine) for acute agitation in schizophrenia and bipolar disorders.

Impel’s products utilize its novel, nasal drug-delivery Precision Olfactory Delivery, or POD™, device technology to deliver liquid or dry powder forms of drug to the upper nasal cavity in a consistent and predictable manner.

IMPEL, POD and the IMPEL Logo are trademarks of Impel NeuroPharma, Inc. To learn more about Impel NeuroPharma, please visit our website at http://impelnp.com.

About Precision Olfactory Delivery™ or POD™ Devices
Impel NeuroPharma’s proprietary POD™ intranasal drug delivery device is designed to deliver drugs to the richly-vascularized upper nasal cavity to achieve superior biodistribution and bioavailability of both small molecules and biologic drugs. By consistently and predictably delivering therapeutics to the upper nasal cavity, the POD nasal delivery device may improve overall bioavailability of drugs. The POD device also has the potential for nose-to-brain delivery via the olfactory and trigeminal nerves. Impel has developed dry powder and liquid compatible POD devices to improve upon current treatment options for central nervous system (CNS) disorders.

Contact:
Melyssa Weible
Elixir Health Public Relations
Ph: (1) 201-723-5805
E: mweible@elixirhealthpr.com

Categories: News

Tags: